| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Interleukin-2 assay (procedure) |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-6 assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-7 assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Mononuclear cell function assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-3 assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Cytokine assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon gamma assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Intracellular free calcium assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| TNF, Beta assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-8 assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Protein kinase C activity assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alpha assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Lymphokine assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon beta assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-4 assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-5 assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Tumor necrosis factor assay |
Has measured component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interleukin-2 assay (procedure) |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-6 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-7 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Mononuclear cell function assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
2 |
| IL-3 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Cytokine assay |
Component |
True |
Cytokine |
Inferred relationship |
Some |
1 |
| Interferon gamma assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Intracellular free calcium assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
2 |
| TNF, Beta assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-8 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Protein kinase C activity assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
3 |
| Interferon alpha assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Lymphokine assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
3 |
| Interferon assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon beta assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-4 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| IL-5 assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Tumor necrosis factor assay |
Component |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing interferon gamma-1b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing interferon beta-1a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing interferon beta-1b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing interferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing cytokine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cytokine |
Inferred relationship |
Some |
1 |
| Product containing aldesleukin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alfa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon beta-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing interferon gamma (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| humant interferon gamma-1b 200 µg/ml injektionsvæske, opløsning, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 10 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 5 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 3 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 1 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 6 MIE/ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon beta-1b 8 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 1million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 4.5million iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 5million units injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 10million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 30million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 3million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 9million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 18million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 3million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons 10million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferons (2) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2a 6 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2a 9 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2a 18 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon beta-1a 6 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 15 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 25 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 50 MIE/1 ml fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 10 MIE/ml injektionsvæske, opløsning, hætteglas a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon beta-1a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon beta-1a 24 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2a 18 MIE/0,6 ml injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 50 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 80 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 100 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 150 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 120 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Product containing interferon alfa-n1 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| aldesleukin 18 ME pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 30 MIE opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 60 MIE/IE opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 150 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 300 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 120 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 600 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 100000 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfa-2b 50 µg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alfa-n3 human leu 5000000unt/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alfa-2a 18000000iu/3mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alfa-2a 36000000iu/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alfa-2a 3miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alfa-2a 6miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| Interferon alfa-2a 9miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon alfacon 130 µg/ml injektionsvæske, opløsning, cylinderampul a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
| interferon beta-1b 100 µg injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Some |
|
FHIR